Related Experiment Videos
Egg-adapted replication-restricted virus protects mice against lethal influenza
1Department of Microbiology, Fukui Medical University School of Medicine, Shimoaizuki 23-3, Matsuoka-cho, Yoshida-gun, Fukui 910-1193, Japan.
Vaccine
|June 17, 2000
Summary
This study explored an egg-adapted (EA) influenza virus strain in mice as a potential live attenuated vaccine. The EA virus showed restricted growth and induced protective immunity against virulent influenza, suggesting its vaccine candidacy.
Area of Science:
- Virology
- Immunology
- Vaccinology
Background:
- Live attenuated virus vaccines offer advantages in inducing broad immunity.
- Developing safe and effective live attenuated influenza vaccines remains a priority.
Purpose of the Study:
- To evaluate the egg-adapted (EA) influenza virus strain as a murine model for a live attenuated vaccine.
- To assess the immunogenicity and protective efficacy of the EA strain in mice.
Main Methods:
- Infection of mice with the EA strain of influenza virus.
- Analysis of viral growth, spread, and inflammatory changes in respiratory tracts.
- Assessment of humoral (IgG, IgA) and cellular (cytotoxic T lymphocyte) immune responses.
- Evaluation of protection against subsequent challenge with virulent influenza virus.
Main Results:
- The EA virus exhibited restricted growth and limited inflammation in mouse lungs.
- Amino acid alterations in the hemagglutinin molecule correlated with reduced fusion activity.
- Intranasal inoculation induced specific antibody and cytotoxic T lymphocyte responses.
- Immunized mice demonstrated significant resistance to lethal influenza challenge.
Conclusions:
- The EA influenza virus strain, with its inherent growth restriction, serves as a suitable candidate for a live attenuated vaccine.
- The observed immunogenicity and protective effects support its potential for human use.